Abstract |
Clostridium difficile is a major cause of antibiotic-associated diarrhoea and the primary cause of pseudomembraneous colitis in hospitalised patients. We assessed the protective effect of anti-surface layer protein (SLP) antibodies on C. difficile infection in a lethal hamster challenge model. Post-challenge survival was significantly prolonged in the anti-SLP treated group compared with control groups (P=0.0281 and P=0.0283). The potential mechanism of action of the antiserum was shown to be through enhancement of C. difficile phagocytosis. This report indicates that anti-SLP antibodies can modulate the course of C. difficile infection and may therefore merit closer investigation for use as constituents of multi-component vaccines against C. difficile associated diarrhoea.
|
Authors | Julie B O'Brien, Matthew S McCabe, Verónica Athié-Morales, George S A McDonald, Déirdre B Ní Eidhin, Dermot P Kelleher |
Journal | FEMS microbiology letters
(FEMS Microbiol Lett)
Vol. 246
Issue 2
Pg. 199-205
(May 15 2005)
ISSN: 0378-1097 [Print] England |
PMID | 15899406
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Bacterial
- Bacterial Proteins
- Membrane Glycoproteins
- S-layer proteins
|
Topics |
- Animals
- Antibodies, Bacterial
(immunology, therapeutic use)
- Bacterial Proteins
(immunology)
- Cell Line
- Clostridioides difficile
(immunology)
- Cricetinae
- Disease Models, Animal
- Enterocolitis, Pseudomembranous
(prevention & control)
- Female
- Humans
- Immunization, Passive
- Membrane Glycoproteins
(immunology)
- Mesocricetus
- Monocytes
- Phagocytosis
|